- Home
- KRYS vs DLB Comparison
KRYS vs DLB Comparison
Compare KRYS & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- DLB
- Stock Information
- Founded
- KRYS 2015
- DLB 1965
- Country
- KRYS United States
- DLB United States
- Employees
- KRYS N/A
- DLB N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- DLB Multi-Sector Companies
- Sector
- KRYS Health Care
- DLB Miscellaneous
- Exchange
- KRYS Nasdaq
- DLB Nasdaq
- Market Cap
- KRYS 6.3B
- DLB 6.2B
- IPO Year
- KRYS 2017
- DLB 2005
- Fundamental
- Price
- KRYS $221.08
- DLB $67.54
- Analyst Decision
- KRYS Strong Buy
- DLB Strong Buy
- Analyst Count
- KRYS 9
- DLB 5
- Target Price
- KRYS $214.22
- DLB $93.60
- AVG Volume (30 Days)
- KRYS 335.7K
- DLB 686.0K
- Earning Date
- KRYS 11-03-2025
- DLB 11-18-2025
- Dividend Yield
- KRYS N/A
- DLB 2.15%
- EPS Growth
- KRYS 275.72
- DLB N/A
- EPS
- KRYS 6.66
- DLB 2.62
- Revenue
- KRYS $373,164,000.00
- DLB $1,349,130,000.00
- Revenue This Year
- KRYS $34.33
- DLB $5.25
- Revenue Next Year
- KRYS $48.04
- DLB $4.51
- P/E Ratio
- KRYS $32.83
- DLB $25.57
- Revenue Growth
- KRYS 54.51
- DLB 5.92
- 52 Week Low
- KRYS $122.80
- DLB $64.02
- 52 Week High
- KRYS $221.84
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- KRYS 76.21
- DLB 54.18
- Support Level
- KRYS $203.17
- DLB $65.13
- Resistance Level
- KRYS $212.97
- DLB $68.00
- Average True Range (ATR)
- KRYS 7.05
- DLB 1.33
- MACD
- KRYS 0.96
- DLB 0.43
- Stochastic Oscillator
- KRYS 98.60
- DLB 86.08
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.